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Abstract 
Although associated with key recovery outcomes, stigma resistance remains under-studied 
largely due to limitations of existing measures. This study developed and validated a new 
measure of stigma resistance. Preliminary items, derived from qualitative interviews of people 
with lived experience, were pilot tested online with people self-reporting a mental illness 
diagnosis (n=489). Best performing items were selected, and the refined measure was 
administered to an independent sample of people with mental illness at two state mental health 
consumer recovery conferences (n=202).  Confirmatory factor analyses (CFA) guided by theory 
were used to test item fit, correlations between the refined stigma resistance measure and 
theoretically relevant measures were examined for validity, and test-retest correlations of a 
subsample were examined for stability. CFA demonstrated strong fit for a 5-factor model. The 
final 20-item measure demonstrated good internal consistency for each of the 5 subscales, 
adequate test-retest reliability at 3 weeks, and strong construct validity (i.e., positive associations 
with quality of life, recovery, and self-efficacy, and negative associations with overall symptoms, 
defeatist beliefs, and self-stigma). The new measure offers a more reliable and nuanced 
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assessment of stigma resistance. It may afford greater personalization of interventions targeting 
stigma resistance. 
Keywords: mental illness, internalized stigma, self-stigma, outcomes, psychometric validation 
1. Introduction
Mental illness stigma consists of negative attitudes, beliefs, and actions toward those with 
mental illness (Link and Phelan, 2001; Wahl, 2012), which frequently leads to negative 
experiences for people with lived experience of mental illness (Corrigan, 2007). Given the high 
prevalence of public stigma (Corrigan, 2004; Lyons and Ziviani, 1995), an additional challenge 
for people with lived experience of mental illness is self-stigma—the awareness of public stigma, 
agreement with these attitudes, and application of these beliefs to oneself (e.g., “I’ll never get 
better,” “I can’t hold a job”; Corrigan and Rao, 2012). Self-stigma has been linked to poorer 
recovery across key domains such as quality of life, symptoms, and hope (Livingston and Boyd, 
2010; Ritsher et al., 2003); self-stigma also has been found to moderate the relationship between 
insight into one’s illness and one’s social functioning, hope, and self-esteem (Lysaker, Roe, and 
Yanos, 2007). 
However, not everyone with lived experience of mental illness internalizes stigma. 
Recent attention has turned to the importance of understanding the conditions in which 
individuals apply stigma to themselves (Thoits, 2011; Thoits and Link, 2015). For example, 
stigma resistance, initially understood as the general process of not internalizing stigma (Ritsher 
and Phelan, 2004), has been strongly linked to several intrapersonal qualities including increased 
self-efficacy, hope, recovery attitudes, insight into one’s illness, and self-stigma, as well as to 
 improved outcomes of increased quality of life and decreased symptoms (Firmin, Luther, 
Lysaker, Minor, and Salyers, 2016). Moreover, stigma resistance involves the application of 
diverse experiences across multiple levels.  A qualitative investigation of stigma resistance from 
the perspective of people with lived experience pointed to stigma resistance being an active, 
ongoing process of using one’s skills, knowledge, and experiences to fight stigma at the 
personal, peer, and public levels (Firmin, et al., 2017).  
 Stigma resistance has primarily been measured using the 5-item Stigma Resistance 
subscale of the Internalized Stigma of Mental Illness Scale (ISMIS; Ritsher et al., 2003). This 
subscale includes reverse-scored, positively-worded items to represent being unaffected by 
stigmatizing attitudes (Ritsher and Phelan, 2004). However, the subscale has demonstrated 
variable to poor internal consistency, which has led to its exclusion in some studies (Mashiach-
Eizenberg, Hasson-Ohayon, Yanos, et al., 2013; Park, Bennett, Couture, et al., 2013). In a recent 
meta-analysis of 45 studies, the average Cronbach’s alpha for the Stigma Resistance subscale 
was only .56 (Firmin, et al., 2016). A second measure that assesses a closely related construct of 
positive identity, with similar wording of items, is the 5-item Positive Aspects subscale of the 
Stigma Scale (King et al., 2007). The Positive Aspects subscale is less widely used and also 
demonstrated room for improvement across three extant studies (.64; Firmin, et al., 2016).   
Although the construct of stigma resistance is linked to key recovery outcomes, and is 
frequently the target of calls for additional research (Nabors et al., 2014; Sibitz, Unger, 
Woppmann, Zidek, and Amering, 2011; Thoits, 2011), it remains under-studied due to 
psychometric limitations. Moreover, the extant measures may not fully reflect the construct of 
stigma resistance. Past theoretical work by Thotis (2011) and recent work establishing a model 
of stigma resistance grounded in the perspectives of people engaged in this process (Firmin et al., 
 2017) both conceptualize stigma resistance as a multi-faceted process, not fully captured by 
either of these subscales. Thus, we sought to develop and validate a new measure of stigma 
resistance. We aimed to produce a measure with strong psychometric properties that reflects the 
multi-faceted conceptualization of stigma resistance grounded in the perspective of people with 
lived experience (i.e., a process that occurs at the personal, peer, and public levels). We utilized 
qualitative interviews regarding stigma resistance (Firmin, Luther, Lysaker, Minor, and Salyers, 
2016) to generate potential items and refined the new measure through validation in two 
independent samples of people who self-report having lived experience with mental illness. 
 
2. Method  
2.1. Participants and Procedure 
 A pool of 54 items was generated from qualitative interviews with 24 individuals doing 
well in their recovery, including peer-providers (n = 14). Items reflected the theoretical model 
developed from these analyses (Firmin et al., 2017) and frequently used direct wording used by 
participants. Items were pilot tested in Amazon’s MTurk survey platform with individuals who 
identified as having lived experience with mental illness. Eligibility criteria included being at 
least 18 years old, an English speaker, as well as reporting a mental health diagnosis. Participants 
were paid $0.50. Ten attention-check items were included to screen poor quality or inattentive 
responding (Chapman and Chapman, 1983). To incentivize careful responding, participants were 
given the opportunity to earn an additional $0.25 compensation bonus for providing quality 
responses (correctly answering at least six out of ten attention-check items). Participants could 
skip any questions they did not wish to answer. A total of 534 individuals participated in the on-
line survey on MTurk. Of those, 31 were removed for answering fewer than 6 attention-check 
 items correctly (e.g., “At times when I was ill or tired, I have felt like going to bed”). One 
participant was removed for indicating an age less than 18 years old. Thirteen participants were 
removed because they attempted to participate more than once. The final MTurk sample was 489 
adults.   
 After conducting the online pilot, 26 of the best performing items were selected (criteria 
discussed below) and administered in person to participants at one of two state-wide annual 
conferences for people with lived experience with mental illness living in the Midwestern U.S. 
(Conference 1 n=96, Conference 2 n=106).  We combined data from both, referred to as the 
“conference sample” throughout. Eligibility criteria included being at least 18 years old, 
speaking English, and reporting a mental health diagnosis. Participants also had the option to 
complete the survey with individual assistance by a researcher. A $10 gift-card was provided to 
participants for completing any part of the survey. Participants at Conference 1 were presented 
the opportunity to complete a test-retest validation phase. Two weeks after the conference, 
interested participants received a copy of the stigma resistance scale and a pre-addressed, 
postage-paid envelope. Sixty-four re-test surveys were mailed and 45 (72%) surveys were 
returned within 3 weeks of being mailed; participants who returned surveys were sent an 
additional $10 gift-card for participation in the re-test phase. All procedures were approved by 
the university IRB.  
2.2. Measures 
 In addition to the stigma resistance items, conference participants provided age, gender, 
race, education level, employment status (hours currently employed if working), marital status, 
and mental health diagnoses. We also administered existing measures of stigma resistance to 
assess construct validity. We assessed criterion validity by examining relationships with 
 outcomes previously linked to stigma resistance.  Hypotheses were made in line with previous 
reviews of stigma-resistance (Firmin, Luther, Lysaker, Minor, and Salyers, 2016), assessing 
whether the new measure also demonstrated positive relationships with prior measures of stigma 
resistance and increased quality of life, self-efficacy, hope, recovery, and whether greater stigma 
resistance was associated with decreased overall symptoms and depressive symptoms.  
Stigma Resistance.  
Our measure of stigma resistance was compared to the 5-item subscale of the Internalized 
Stigma of Mental Illness Scale (ISMI; Ritsher et al., 2003). As in prior research (Firmin, Luther, 
Lysaker, Minor, and Salyers, 2016), the Stigma Resistance subscale of the ISMIS had variable 
reliability, with Cronbach’s alpha of .66 in the MTurk sample and .81 in the Conference sample. 
Positive Aspects of Mental Illness.  
The 5-item Positive Aspects subscale of the Stigma Scale (King et al., 2007) was also 
used to assess construct validity. This subscale was only administered to the conference sample 
and the reliability was adequate (.66).  
Self-Stigma.  
The Internalized Stigma of Mental Illness Scale (ISMIS) was used to assess self-stigma 
(Ritsher, et al., 2003), with higher scores indicating greater self-stigma. Similar to others 
(Hasson-Ohayon et al., 2014; Sibitz et al., 2011), we calculated a total-score using the mean of 
items in the 4 subscales excluding the stigma resistance subscale. The ISMIS demonstrated good 




 Perceived Public Stigma.  
The 12-item Perceived Devaluation Discrimination Questionnaire (PDD) scale was used 
to assess perceptions of public stigma, with higher scores indicating greater perceived stigma 
(Link, 1987). Internal consistency was good in both samples (MTurk=.88, Conference=.82).  
Recovery Assessment Scale.  
We measured perceptions of global recovery using a brief, 20-item version of the 
Recovery Assessment Scale (RAS; Corrigan, Giffort, Rashid, Leary, and Okeke, 1999; Corrigan, 
Salzer, Ralph, Sangster, and Keck, 2004). The brief version of the RAS has been used previously 
in samples of people with serious mental illness to assess attitudes and beliefs about recovery 
and one’s ability to make progress toward life goals. Higher scores reflect more positive 
recovery attitudes, and the total score reliability was good for both samples (Mturk=.89, 
Conference=.95).  
Quality of Life.  
We used an abbreviated version of the World Health Organization Quality of Life 
(WHOQOL-BREF; Skevington, Lotfy, and O'Connell, 2004) that has been widely used in 
mental health samples and linked with greater stigma resistance (Luther et al., 2015; Sibitz et al., 
2011). Each item asks about subjective satisfaction regarding a life domain (e.g., physical health, 
social relationships) as well as overall life satisfaction. Higher mean scores reflect greater self-
reported quality of life.  The scale demonstrated good reliability in both samples (.93).  
Overall Symptoms.  
The Colorado Symptom Inventory was used as a self-report measure of overall 
psychiatric symptoms. This 14-item measure has been widely used in diverse samples of persons 
with mental illness (Conrad et al., 2001; Piland, Motl, Ferrara, and Peterson, 2003) and captures 
 a range of symptoms, including psychotic symptoms and mood symptoms. A total score 
reflected greater self-reported psychiatric symptoms; the scale demonstrated good reliability in 
both samples (MTurk=.89, Conference=.93).  
Defeatist Beliefs.  
We used the 15-item defeatist performance beliefs subscale of the Dysfunctional Attitude 
Scale (DAS; Grant and Beck, 2009) to assess how participants believe they perform tasks most 
of the time (e.g., “If I fail, it is as bad as being a complete failure”). Higher scores indicate 
greater defeatist beliefs. We used the total score of the defeatist performance beliefs subscale. 
The DAS demonstrated excellent reliability in both samples (MTurk=.93, Conference=.92).   
Self-Efficacy.  
The Self-Efficacy Scale (Schwarzer, Bäßler, Kwiatek, Schröder, and Zhang, 1997) was 
used to assess beliefs about general self-efficacy. Participants respond to 10 statements that 
reflect optimistic self-beliefs (e.g., “I can usually handle whatever comes my way”) and indicate 
how much they believe the statements are true. Higher scores reflect greater perceived self-
efficacy.  Good reliability was observed in both samples (MTurk=.89, Conference=.92). This 
measure has been used in diverse mental health samples and in prior studies assessing stigma 
(Kleim et al., 2008; Schwarzer et al., 1997). 
2.3. Analyses 
Analyses were conducted in several steps. First, data was screened for normality and 
outliers (study variables fell within acceptable ranges using Kline’s (2011) guidelines). We 
randomly selected a subsample of the MTurk sample (n=161) for item-level descriptive statistics 
and exploratory factor analysis (EFA), not including a second sub-sample (n=328) of the initial 
MTurk sample for confirmatory factor analyses (CFA). Poor-performing items were identified 
 and removed if they met the following criteria: (1) floor or ceiling effects (defined by less than 
5% or more than 80% endorsed the highest or lowest category, respectively), (2) low factor 
loadings (<.7; Hair et al., 2006), or (3) low item-total correlations (<.4; Monahan, Lane, Hayes, 
McHorney, and Marrero, 2009). Similarly-worded items or items that assessed similar domains 
were compared and the better performing items within a broad domain were retained. Items were 
selected to fit the theoretical model previously identified (Firmin et al., 2017). EFAs were run 
using principal components with viramax rotation to determine the potential number of factors 
using scree plot loadings, with Eigenvalues greater than 1 considered (Jolliffe, 2002).  
A series of CFAs were then conducted in the remaining MTurk sample (n = 328) and 
then in the conference sample, testing the potential models suggested by the EFA. The following 
guidelines were used to assess model fit: (1) standardized root mean square residual (SRMR) < 
.08 was acceptable and <.05 good; (2) root mean square error of approximation (RMSEA) <.08 
was acceptable and <.05 good; and (3) comparative fit indices (CFI) >.90 were acceptable and 
<.95 were considered good (Browne and Cudeck, 1992; Hu and Bentler, 1999). Finally, in order 
to further refine the measure across a heterogeneous sample, we combined the MTurk sub-
sample (n=328) with the conference sample (n=202) to test the CFA model with the strongest 
support in both the MTurk sample and the conference sample. Item performance was then 
assessed and redundant items removed to produce a parsimonious final measure with strong 
model fit.  
Internal consistency of the final scale was examined for the total scale and each factor. 
For a subsample who completed the measure twice, test-retest reliability was assessed using 
Pearson correlation. Finally, construct validity was assessed by conducting bivariate correlations 
 between the new SR measure total, subscales, and each recovery-related domain assessed. 
Analyses were conducted using SPSS version 22 and Mplus. 
 
3. Results 
3.1. Sample Characteristics 
In the MTurk sample, 489 adults provided usable data. Participants were primarily White 
(n=435, 85.8%), female (n=362, 71.4%), employed (n=328, 64.7%; average hours=36.3, 
S.D.=10.5), and the mean age was 33.5 (S.D.=11.2). The most commonly reported mental health 
diagnoses included: depression (39.3%), anxiety (26.4%), Bipolar disorder (8.5%), ADHD 
(6.1%), and PTSD (5.9%). The second sample was obtained from the conferences (n=202). 
Conference participants were also largely White (n=128, 62.2%), female (n=135, 68.2%), 
employed (n=129, 64.5%; average hours=27.4, S.D.=12.7), and the mean age was 47.9 
(S.D.=11.7). The most commonly reported mental health diagnoses included: depression 
(39.3%), anxiety (26.4%), Bipolar disorder (8.5%), ADHD (6.1%), and PTSD (5.9%) 
Because the final stage of measure refinement would benefit from a large, diverse sample, we 
combined the sub-sample from MTurk and the conference sample.  See Table 1 for 
demographics of each of the samples.  
3.2. Item Selection and Preliminary Factor Structure 
 The initial 54 items were administered online using MTurk. Data from a random 
subsample (30%, n=161) were selected for initial item analysis. Items were removed for 
restricted range of responses (3 items removed) or for low item-total correlations (<.40, 11 items 
removed). The remaining items were grouped into one of the three originally conceptualized 
theoretical domains (i.e., personal, peer, and public stigma resistance) and similarly-worded 
 items were compared to select the best performing items representative of the theoretical 
domains. An EFA revealed several potential factor structures could be statistically appropriate 
for the remaining 26 items, including a 1, 3, or 5 factor model (see Figure 1 for the Scree Plot of 
Eigen values greater than 1). Each of these models were tested in subsequent CFAs. 
3.3. Confirmatory Factor Analyses and Measure Refinement 
The preliminary 26-item measure was then administered to 202 conference participants. 
CFAs were conducted independently in the conference sample and in the MTurk sub-sample 
(n=328). As shown in Table 2, fit indices indicated that the 5-factor model demonstrated the 
strongest fit in the MTurk data (SRMR=0.07, RMSEA=0.08, CFI=0.85, χ2(299)=1330.1, 
p<0.001) and in the conference data (SRMR=0.06, RMSEA=0.09, CFI=0.86  χ2(289)=723.4, 
p<0.001). To further refine the measure, the samples in which independent CFAs were 
conducted were combined for a total sample of 530 participants. Using all 26 items, a new CFA 
confirmed that a 5-factor model demonstrated good fit in the combined sample (SRMR=0.05, 
RMSEA=0.07, CFI=0.91, χ2(289)=938.6, p=0.001).  
In order to produce a parsimonious measure with strong psychometric properties, we 
selected the best performing items using the following steps. Six items were selected for removal 
for having lower factor loadings and redundancy with other items within a factor. The final scale 
demonstrated strong fit (SRMR=0.04, RMSEA=0.06, CFI=0.94, χ2(160)=484.6, p=0.001) and 
consists of 20 items organized into 5 factors. The final factors reflect five domains of stigma 
resistance: (1) self-other differentiation (3 items reflecting the ability to separate the stigmatizing 
thoughts and attitudes of others from one’s own perspective), (2) personal identity (4 items on 
meaning one finds in life outside their mental illness), (3) personal cognitions (3 items on 
cognitive strategies employed in challenging negative thoughts regarding mental illness), (4) 
 peer stigma resistance (5 items reflecting a desire to use one’s experience to help others with 
stigma), and (5) public stigma resistance (5 items on ways people challenge public stigma). Item 
performance in the combined sample for the final 20 items is listed in Table 3. 
3.4. Reliability  
 The Cronbach’s alpha for each of the subscales demonstrated acceptable to good 
reliability: Self-other differentiation=.71, Personal Identity=.85, Personal Cognitions=.82, 
Peer=.75, Public=.88. Forty-five participants from Conference 1 participated in the test-retest 
phase, and the 20-item measure had adequate to good reliability over a 3 week period for most 
subscales (Self-other differentiation r=.58; Personal Identity r=.67; Personal Cognitions r=.59; 
Public=.61); lower test-retest reliability was observed for the Peer domain (r=.46). Internal 
consistency for the total measure was excellent (α=.93), and test-retest over 3 weeks was also 
good (r=.74). 
3.5. Construct Validity 
 Finally, using the combined sample, associations were assessed between the new 
measure, related constructs, and recovery-related domains (Table 3). The total Stigma Resistance 
Scale score was associated in expected directions with each construct assessed at the p<.001 
level. First, the Stigma Resistance Scale demonstrated a positive association with being able to 
see the positive in having a mental health diagnosis (r=.47). Although the new measure was 
negatively related to the overall ISMIS (r=-.39), a weaker relationship was observed with the 
stigma resistance subscale of the ISMIS (r=.16).  
Significant positive relationships were also observed between stigma resistance and self-
efficacy, recovery attitudes, and quality of life, as well as significant negative associations with 
perceived public stigma, symptoms, and defeatist beliefs. At the subscale level, personal-level 
 stigma resistance factors also demonstrated construct validity with significant correlations in 
meaningful domains. Notably, greater personal identity was associated with greater recovery 
attitudes and self-efficacy (r=42 and .54), and the personal cognition subscale was associated 
with lower defeatist performance beliefs (r=-.44).  
 
4. Discussion 
This study developed a new, reliable, and valid measure of stigma resistance that 
overcomes limitations of previous measures and is grounded in a theoretical understanding of 
stigma resistance derived from the perspectives of people with lived experience. Using a 
systematic, developmental approach, the Stigma Resistance Scale is a 20-item measure 
demonstrating a 5-factor structure, reflecting distinct, but related, domains of resisting stigma: 
(1) self-other differentiation, (2) personal identity, (3) personal cognitions, (4) peer stigma 
resistance, and (5) public stigma resistance. Internal consistency was adequate for each subscale 
(.72-.88), and the overall measure (.93). The measure also demonstrated good consistency over a 
3-week period.  
The Stigma Resistance Scale demonstrated moderate to strong construct validity, 
significantly associated in the expected direction with each hypothesized construct. The strongest 
associations (moderate to large effect sizes) were observed between overall stigma resistance and 
self-efficacy (r=.54), defeatist beliefs (r=-.47), and seeing the positive aspects of mental illness 
(r=.47). The magnitude of associations observed in this study are consistent with effect sizes 
reported in a recent meta-analysis of associations between another measure of stigma resistance 
(ISMIS) and psychiatric and psychosocial outcomes (Firmin, Luther, Lysaker, Minor, and 
Salyers, 2016). While additional research is needed to confirm these associations, our initial 
 findings suggest the Stigma Resistance Scale reflects a construct that is central to several key 
aspects of recovery. 
Some observations between the Stigma Resistance Scale and other measures were 
smaller than hypothesized. For example, the associations with the new measure and the ISMIS 
stigma resistance subscale was smaller than expected (r=.16, p<.001). One potential explanation 
for the weaker than expected associations observed may be due to differences in content covered 
across the two scales. In particular, public stigma beliefs, which do not necessarily assess stigma 
directed toward the self, are reflected in two of the five ISMIS subscale items (e.g., “I feel 
comfortable being seen in public with an obviously mentally ill person” and “People with mental 
illness make important contributions to society”). Thus, content assessed by the stigma resistance 
subscale of the ISMIS may overlap partially with content covered by the new measure, but we 
suggest it does not map as well onto domains reported as key by people with lived experience 
(Firmin et al., 2017).  
The new Stigma Resistance Scale improves upon the stigma resistance subscale of the 
ISMIS in several ways. First, the internal consistency of the new measure’s total scale (.93) is 
much better than the internal consistency of the ISMIS subscale in this study (MTurk sample 
alpha=.66, Conference sample alpha=.81) and in prior studies, where values ranged from .03 - 
.76; Firmin, Luther, Lysaker, Minor, and Salyers, 2016; Ritsher et al., 2003; Ritsher and Phelan, 
2004). Furthermore, the new Stigma Resistance Scale assesses multiple domains of stigma 
resistance. This conceptualization of the construct was critical given that prior work found 
stigma resistance is a multidimensional construct (Thoits, 2011; Firmin et al., 2017).  
Specifically, the Stigma Resistance Scale was developed from a conceptual model of 
stigma resistance involving (1) Personal stigma resistance, (2) Peer stigma resistance, and (3) 
 Public stigma resistance (Firmin et al., 2017). However, a 5-factor model, initially suggested by 
the EFA and confirmed through CFA, consistently outperformed the 3-factor model. Two 
domains of stigma resistance from the qualitative study (i.e., Peer and Public) are directly 
reflected in the current factor structure. The third domain, the Personal stigma resistance, was 
better structured with 3 subcomponents: Self-other differentiation, Personal identity, and 
Personal cognitions. Thus, while the final scale reflects 5-factors, we believe it remains 
consistent with the broad domains of the 3-factor model of stigma resistance on which it was 
developed.    
This study has several limitations highlighting future research opportunities. First, the 
MTurk and conference participants were primarily White and female. Future work should 
examine how the intersection of multiple identifies, particularly disadvantaged identities, may 
interact as these impact one’s experiences with stigma and stigma resistance (Grollman, 2014; 
Gary, 2005). A relatively small number of participants from each sample had a psychotic 
disorder; given work suggesting stigma may be particularly poignant and worse for people with 
these experiences (Corrigan, 2007), future work should example whether/how stigma resistance 
may differ for this sub-sample. Second, all measures used were self-report, and future work 
could use assessment tools that reduce shared method variance, such as clinician-rated diagnoses, 
functioning, or symptoms. Third, additional assessments are needed to further examine the 
discriminant validity and construct validity of domains that emerged in this work. For example, 
meta-cognition was not formally assessed but has been associated with stigma resistance (Nabors 
et al., 2014). A fourth limitation is that we did not specifically ask about participants’ level of 
peer involvement and formal advocacy; assessing these variables in the future could provide 
additional criterion-related validity and help inform whether the factors are developmental – for 
 example, do individuals first engage in personal stigma resistance, then peer, and then public. A 
final limitation is that the new measure focuses on positive activities associated with stigma 
resistance, and we did not investigate potential negative reactions or ways people resist stigma 
(e.g., avoidance, anger).  
Findings from this study suggest several possible clinical applications, including the 
potential to inform intervention targets and guide treatment. It may be that someone who scores 
low on the Self-other differentiation subscale may be particularly well suited for metacognitive 
therapy or self-stigma interventions such as Narrative Enhancement and Cognitive Therapy (Roe 
et al., 2014; Yanos et al., 2011). Similarly, individuals who score lower on the Personal 
Cognitions subscale may be good candidates for CBT-oriented therapies that address self-stigma 
(Lucksted et al., 2011; Yanos, Lucksted, Drapalski, Roe, and Lysaker, 2015). Low scores on 
Peer Stigma Resistance might point to opportunities to work with peers (e.g., employment as a 
peer specialist or volunteer opportunities) as beneficial (Davidson et al., 2012; Firmin et al., 
2015). For those scoring low on Public Stigma Resistance, advocacy training, experiences 
practicing sharing one’s story, and support for decisions about personal disclosures (Corrigan et 
al., 2013; Rüsch et al., 2014) may assist individuals in this domain of stigma resistance. Having a 
tool that reflects distinct, and potentially sequential, facets of stigma resistance may allow 
clinicians to tailor appropriate interventions.  
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(mean, SD) 37.4 (11.6) 47.9 (11.7) 39.3 (13.3) 
Sex (n, % Female) 234 
(71.3%) 
135 (68.2%) 369 (70.2%) 
Race (n, % White) 283 
(86.3%) 
128 (62.2%) 411 (77.5%) 
Education (% with bachelor’s degree or above) 134 
(40.9%) 
44 (21.8%) 178 (33.6%) 
Employment (% currently employed) 115 
(35.1%) 
129 (64.5%) 244 (46.2%) 
If employed, average hours per week (mean, SD) 36.2 (10.0) 27.4 (12.7) 34.7 (11.0) 
Marital status (% never married) 169 
(51.5%) 
90 (44.6%) 259 (48.9%) 
Mental health diagnosis    
   Anxiety 91 (27.7%) 34 (16.8%) 125 (23.6%) 
   Depression 132 
(40.2%) 
45 (22.3%) 177 (33.4%) 
   Schizophrenia-spectrum 1 (0.3%) 51 (25.3%) 51 (9.6%) 
   Bipolar disorder 30 (9.1%) 36 (17.8%) 66 (12.5%) 
   Substance use 9 (4.5%) 5 (1.5%) 14 (2.6%) 
   Other (e.g., ADHD, personality disorder, PTSD) 19 (9.4%) 68 (20.7%) 87 (16.4%) 
Final Stigma Resistance Scale: 20 item
a  
   Self-other differentiation SR 
   Personal Identity SR 
   Personal Cognitions SR 
   Peer SR 































2.0 (0.6) 2.1 (0.8) 2.1 (0.7) 
Perceived Public Stigma
b 
2.9 (0.5) 2.6 (0.5) 3.0 (0.7) 
Recovery Assessment Scale
a 
4.8 (0.8) 4.1 (0.7) 4.5 (0.8) 
Quality of Life
a 
















Note: Missing values ranged from 3 -12 for all variables except for the RAS, QL, and DAS. Due to a copying error, those 3 
measures were omitted from several surveys and missing values range from 31-35. N’s varied from 319 -328 in the MTurk 
sample and 191 –202 in the Conference sample.  
a
=Scales range from 1 to 5 with greater scores meaning more of the construct. 
b
=Scales range from 1 to 4 with greater scores meaning more of the construct. 
c
=Scales range from 1-7 with greater scores 




 Table 2. Confirmatory Factor Analysis Data 
Sample Model Total  
Items 
Fit Indices 
SRMR RMSEA CFI χ2 
MTurk Unidimensional 26 0.08 0.10 0.73 1330.08 (299) 
MTurk 3 factors 26 0.07 0.09 0.79 1100.34 (296) 
MTurk 5 factors 26 0.07 0.08 0.85 571.18 (289) 
Conference Unidimensional 26 0.06 0.10 0.81 897.04 (299) 
Conference 3 factors 26 0.06 0.10 0.83 839.12 (296) 
Conference 5 factors 26 0.06 0.09 0.86 723.36 (289) 
Combined 5 factors 20a 0.04 0.06 0.94 484.60 (160) 
Note: All χ
2 
values were significant at the p<.0001 level. 
a
Items 11, 18, and 23-26 removed. 
 
Table 3. Item Performance of the Final 20 Items and 5-factor Model in Final Combined Samples (N=530) 
 Total Scale 
(20 items) 
Subscales 
(5 factor model) 
















1. I can have a positive view of myself even 
when others don’t have a positive view of 
me. 
.63 .93 .55 .59 
 2. When I encounter sigma, I can think of 
why these attitudes are wrong. 
.64 .93 .56 .59 
 3.  Resisting Stigma means doing what I want 












4. I can have a good, fulfilling life, despite my 
mental illness. 
.66 .93 .70 .80 
5.  I have done meaningful things in my life 
since having a mental illness. 
.63 .93 .69 .80 
 6.  I know there is more to me than my 
mental illness. 
.66 .93 .73 .79 
 7.  My diagnosis does not define me.  .65 .93 .63 .83 
Personal 
Cognitions 
8. I challenge negative thoughts that I may 
have about myself related to having a 
mental illness.  
.57 .93 .55 .87 
 9. To resist stigma, I think about positive 
things about myself. 
.62 .93 .63 .65 
 10. I actively tell myself positive things to 
help resist stigma. 
.65 .93 .60 .71 
Peer Stigma 
Resistance 
11. I encourage others who have a mental 
illness by showing them there is hope. 
.72 .93 .72 .85 
12. My lived experiences with mental illness .72 .93 .75 .84 
 can help others with their recovery. 
 13. The way I live shows other people that 
stigma is wrong. 
.69 .93 .65 .86 
 14. I help others resist stigma by showing 
that person I believe in them. 
.67 .93 .70 .85 
 15. I help others see they should not be 
ashamed about mental illness. 
.69 .93 .71 .85 
Public Stigma 
Resistance 
16. I share my story with others to let them 
know about mental illness and recovery. 
.56 .93 .48 .72 
 17. I question the misinformation I hear 
from others about mental illness.  
.40 .93 .50 .70 
 18. Resisting stigma means speaking up 
when others say negative things about 
mental illness. 
.47 .93 .52 .70 
 19. I advocate for better treatment for 
people with mental illness. 
.59 .93 .54 .69 
 20. I believe teaching others about mental 
illness is a way to fight stigma. 
.58 .93 .54 .70 
 
Table 4. Correlation Matrix in Combined Data of the 20-item Total and 5-factor Sub-scales  
 1 2 3 4 5 6 7 8 
1. SR-New Total 1.0        
2. Self-other differentiation SR  .81*** 1.0       
3. Personal Identity SR .84*** .59*** 1.0      
4. Personal Cognitions SR .78*** .64*** .59*** 1.0     
5. Peer Stigma Resistance .89*** .61*** .68*** .63*** 1.0    
6. Public Stigma Resistance .83*** .50*** .56*** .56*** .73*** 1.0   
7. Positive Aspects  .47*** .40*** .40*** .42*** .43*** .39*** 1.0  
8. Old SR (ISMIS subscale) .16*** .12** .08 .09* .18*** .16*** .16* 1.0 






















-.13** -.09* -.12 -
.19*** 
11. Self-Efficacy .54*** .47*** .54*** .51*** .43*** .33*** .49*** .05 
12. Recovery Attitudes .38*** .35*** .42*** .37*** .28*** .22*** .40*** .45*** 
13. Quality of Life  .38*** .36*** .38*** .40*** .24*** .30*** .31*** .10 





























Note: *=<.05, **=<.01, ***=<.001. The PA was only administered in the Conference sample (n = 195). 
Highlights 
 The new measure of stigma resistance has strong psychometric properties and 
demonstrates improved construct validity compared to previous tools 
   
 Stigma resistance is linked to key psychometric and psychosocial outcomes 
 
 The new measure may assist in greater personalization of stigma resistance interventions 
 
 
